Characterisation and classification of oligometastatic disease: a European Society for Radiotherapy and Oncology and European Organisation for Research and Treatment of Cancer consensus recommendationMatthias Gückenberger, Piet Ost, Yolande Lievens et al.|The Lancet Oncology|2020Cited by 1.1k
Defining oligometastatic disease from a radiation oncology perspective: An ESTRO-ASTRO consensus documentYolande Lievens, Wendy A. Woodward, James B. Yu et al.|Radiotherapy and Oncology|2020Cited by 646
Recommendations for radiation therapy in oligometastatic prostate cancer: An ESTRO-ACROP Delphi consensusThomas Zilli, Claus Belka, Vérane Achard et al.|Radiotherapy and Oncology|2022Cited by 98
Recommendations for the use of radiation therapy in managing patients with gastrointestinal malignancies in the era of COVID-19Leila T. Tchelebi, Karyn A. Goodman, Karin Haustermans et al.|Radiotherapy and Oncology|2020Cited by 47
Critical appraisal of the role of volumetric modulated arc therapy in the radiation therapy management of breast cancerLuca Cozzi, Marta Scorsetti|Radiation Oncology|2017Cited by 33